We are pioneers, leaders, innovators.
From founder Elizabeth Cullum to current Physician-in-Chief Lisa DeAngelis, women have been central to MSK’s 135-year history. They continue to make MSK the world-class institution it is today. MSK leaders recognize the need to attract and support outstanding female scientists and clinicians.
Photo: In May 2018, women leaders from across MSK gathered for a photo shoot for the cover of our flagship publication, MSK News. The issue highlighted the contributions that these women have made as scientists, doctors, and nurses.
Recent Honors and Awards
Sloan Kettering Institute molecular biologist Maria Jasin was awarded the 2019 Shaw Prize in Life Science and Medicine. Dr. Jasin was recognized for her work showing that localized double-strand breaks in DNA stimulate recombination in mammalian cells. This seminal work paved the way for contemporary genome-editing tools such as CRISPR.
SKI chemical biologist Yael David and physician-scientist Adrienne Boire received a 2019 Pershing Square Sohn Prize. The prizes are awarded annually to early career scientists to encourage them to take risks and pursue their boldest research.
SKI tumor immunologist Andrea Schietinger received a Lloyd J. Old STAR Program grant from the Cancer Research Institute for her work in immune cell dysfunction in tumors. The $1.25 million grant supports innovative work with the potential to produce transformative leaps forward in tumor immunology research.
Training and Support
Students and postdoctoral fellows who come to MSK can expect mentorship opportunities with female scientists who are leaders in their fields. Ushma Neill, Vice President of Scientific Education and Training at MSK, is a valuable resource for incoming and current trainees.
The Gerstner Sloan Kettering Graduate School of Biomedical Sciences hosts a Women in Science group for graduate students. Its mission is to promote support for women in science and encourage open dialogue to help address their unique needs and concerns.
Go inside the lab of physician-scientist Adrienne Boire from the Human Oncology and Pathogenesis Program